Introduction {#sec1-1}
============

Chronic cough is a common respiratory disease in clinic which has one month to several years long course. Patients with chronic cough are always accompanied by Bronchial Hyper Responsiveness (BHR) whose manifestations are excessive contraction of bronchial smooth muscle, an increase in Bronchial secretion, narrowing of lumen, limitations in air flow velocity, etc (Group of Asthma Respiratory Society, 2009; Group of Asthma Respiratory Society, 2008). As diseases caused by Bronchial Hyper Responsiveness (BHR), Cough Variant Asthma, Upper Bronchial Cough Syndrome, Gastroesophageal Reflux Cough, Chronic Bronchitis, Bronchiectasis accounts for 70%-95% chronic cough etiology in respiratory medicine clinic (Ward et al, 2002). Based on many years clinical experience in treatment of chronic cough and persistent cough as well as combined with Chinese Traditional Medicine, the writer adopted Ziyinqingre prescription to treat BHR cough, which proved has significant effects.

Based on the previous study about BHR related inflammatory cytokines, we hypothesize that the mechanism of Ziyinqingre prescription on treating BHR cough is probably related to regulating inflammatory cytokines IL-4, IFN-γ. In order to explore on the therapeutic mechanism of Chinese Traditional Medicine, this paper focuses on clinical observations as follows:

Data and Methods {#sec1-2}
================

Clinical Data {#sec2-1}
-------------

We chose 84 patients in General Hospital of PLA from September 2012 to March 2014, who met the diagnostic standard of BHR cough: the result of Air Passage Provocation test was positive (referring to Bronchial Asthma Control Guide established by Respiratory Branch of Chinese Traditional Medicine Association).

**Inclusion criteria:** (1) the result of Air passage provocation test is positive; (2) having throat discomfort, accompanied by cough, expectoration or not, medical history is more than one month; (3) People who are allergic to cold air, smoke and dust, tend to have symptoms of cough and expectoration; (4) Age from 18 to 65.

**Exclusion criteria:** (1) People who have asthma attack or medical history of asthma; (2) The result of Air Passage Provocation test is negative; (3) People who are not willing to take Air Passage Provocation test or participate in this research; (4) People who don't fit for this research because of other diseases.

84 patients with BHR cough were divided into two groups. There are 25 males and 17 females in Chinese Traditional Medicine group whose age from 18 to 62, average age is (46.2±9.3), the course of the disease is from 1 month to 1 year, average course is (0.7±0.3) year. There are 26 males and 16 females in control group whose age from 19 to 64, average age is (48.5±10.2), the course of the disease is from 1 month to 1.5 years, average course is (0.8±0.5) years. The two groups of patients with gender, age, course of disease, as there was no significant statistical difference (*P*\> 0.05), are comparable.

Treatment Methods {#sec2-2}
-----------------

Chinese Traditional Medicine group took Ziyinqingre prescription which composes of Radix Glehniae, Radix Ophiopogonis, Rhizoma Anemarrhenae, Huang Qin, forsythia and reed root each 15 grams; 15 grams Quangualou and 10 grams almond were added for patients with much phlegm; 15 grams Arctium lappa and 3 grams Senmen Oroxyli were added for patients with symptom of throat itching. (all Chinese Traditional Medicine was bought from Bei Jing Tong Ren Tang Technology Development Co. Ltd). One dose a day, decoction, twice a day. The control group took Montelukast Sodium Tablets (bought from Hang Zhou Mo Sha Dong Pharmaceutical Co. Ltd., State Approve No. J20110076) for treatment. For oral use, 10mg, once a day. The treatment course of two groups is two weeks.

Outcome Measures {#sec2-3}
----------------

1\. **Clinical symptoms:** the symptom integral changes of cough, difficult expectoration and throat itching were observed before and after the treatment. Standards of classification were referred to Chinese Traditional Medicine Quantization Diagnosis(1997 First Edition) edited by Xu Dihua.

2). **Indicators of Bronchial Responsiveness:** We adopted Bronchial Responsiveness testing machine (made by Japanese Chest company, Astograph-21) to test the improvement of Rrs, Dmin and sGrs after treatment.

**PB IL-4, IFN---γ:** Subjects, on empty stomach for 12 hours, were drawn 3ml vein blood to separate plasma for testing. IFN---γ was tested by enzyme-linked immunoassay. The kits were supplied by Beijing Kang Yuan Rui De Bio-Tech Co., Ltd. Testing machine was supplied by Finland WellsCan automatic ELISA instrument. IL-4 was tested by radioimmunoassay (RIA), The kits were supplied by Beijing Pu Rui Kang Bio-Tech Co., Ltd. Testing machine was supplied by Shanghai He Suo Ri Huan Photoelectric Instruments Sn-695B immunology counter. All testing steps were strictly followed by instructions.

**Efficacy Evaluation Criteria:** According to Chinese Traditional medical symptomatology curative assessment in Chinese Traditional medicine new drug clinical research guiding principle (issued by State Drug Administration, May 2002, first edition) : (1) clinical cure: clinical symptoms and signs disappear or largely disappear; score of TCM symptoms decreases \>95%.(2) Significantly effective: clinical symptoms and signs are improved significantly, score of TCM symptoms decreases \>70%. (3) Effective: clinical symptoms and signs are improved, score of TCM symptoms decreases \>30%.(4) Not effective: clinical symptoms and signs aren't improved or worse, score of TCM symptoms decreases less than 30%.

Curative effect = (scores before treatment -- scores after treatment) + scores before treatment χ 100°%.

**Statistics:** SPSS13.0 statistics software was adopted. Rank sum test and analysis of variance was adopted. P\<0.05 was considered to be statistically significant.

Results {#sec1-3}
=======

1). Symptom score comparisons between two groups after treatment {#sec2-4}
----------------------------------------------------------------

Patients' symptoms of the two groups are all alleviate in different degrees. Treatment group are better than control group in alleviating cough, difficult expectoration and throat itching. There are significant differences between the two groups. (*P*\<0.05) See [Table 2](#T1 T2){ref-type="table"}.

###### 

Symptoms Standards Classification of Traditional Chinese Medicine

  Symptoms              Grades               Scores   Symptom
  --------------------- -------------------- -------- ----------------------------------------------------------------------------------------
  Cough                 None                 0        
                        Slightly cough       1        slightly cough, two or three coughs at one time; only cough two or three times a day.
                        Heavily cough        2        heavily cough, six or seven coughs at one time; cough four to nine times a day.
                        Severe cough         3        severe cough, frequent coughs; or cough frequently, cough ten times a day even an hour
  Difficult             None                 0        
  Expectoration                                       
                        Slightly difficult   1        slightly difficult expectoration, cough up one or
                        expectoration                 two times for phlegm.
                        Difficult            2        difficult expectoration, cough up three or four
                        expectoration                 times for phlegm.
                        Very difficult       3        very difficult expectoration, cough up five or six
                        expectoration                 times for phlegm. Symptoms of vomiting, dull pain in stomach, dark-purple complexion.
  Throat itching None   None                 0        
                        Slightly throat      1        slight throat itching, just starts or happens
                        itching                       occasionally. Symptoms of coughing or expectoration.
                        Heavily throat       2        rather obvious throat itching, upsetting.
                        itching                       Symptoms of coughing and expectoration.
                        Severe throat        3        couldn't bear throat itching which causes
                        itching                       frequent coughing and anxiety. Desire for
                                                      medical care.

###### 

Symptom score comparisons between two groups after treatment (*x̄* ± *s*)

  Group                      Cough                                                                        Difficult expectoration                                                      Throat itching
  ----------------- -------- ---------------------------------------------------------------------------- ---------------------------------------------------------------------------- ----------------------------------------------------------------------------
  Control group     before   2.59±0.20                                                                    2.37±0.28                                                                    2.48±0.25
  (n=42)            after    1.68±0.18[\*](#t2f1){ref-type="table-fn"}                                    1.57±0.15[\*](#t2f1){ref-type="table-fn"}                                    1.62±0.16[\*](#t2f1){ref-type="table-fn"}
  Treatment group   before   2.65±0.23                                                                    2.42±0.30                                                                    2.54±0.27
  (n=42)            after    1.06±0.14[\*](#t2f1){ref-type="table-fn"}^[Δ](#t2f2){ref-type="table-fn"}^   1.08±0.13[\*](#t2f1){ref-type="table-fn"}^[Δ](#t2f2){ref-type="table-fn"}^   1.11±0.15[\*](#t2f1){ref-type="table-fn"}^[Δ](#t2f2){ref-type="table-fn"}^

**Note:** Fcomparisons between groups

P\<0.05 compared with control group,

pΔP\<0.05.

2). Effect comparisons {#sec2-5}
----------------------

There are 14 cases significantly effective, 23 cases effective, total effective rate reaches 88.1% in treatment group; there are 6 cases significantly effective; 24 cases effective in control group, total effective rate is 71.4%. There are significant differences in two groups. (*P*\<0.05) See [Table 3](#T3){ref-type="table"}.

###### 

Effect Comparisons \[(%)\]

  Group                    Significantly Effective   Effective    Not Effective   Total Effective Rate
  ------------------------ ------------------------- ------------ --------------- ---------------------------------------
  Control Group (n=42)     6 (14.3%)                 24 (57.1%)   12 (28.6%)      71.4%
  Treatment Group (n=42)   14 (33.3%)                23 (54.8%)   5 (11.9%)       88.1%[\*](#t3f1){ref-type="table-fn"}

Note:comparisons between groups,

P\<0.05,

3). Comparisons in indicators of Bronchial responsiveness between two groups {#sec2-6}
----------------------------------------------------------------------------

The level of Dmin increased and Rrs level decreased significantly in both groups (*P*\<0.05), but more significantly in treatment group. See [Table 4](#T4){ref-type="table"}.

###### 

Comparisons in indicators of Bronchial responsiveness (*x̄*±*s*)

  Group                      Rrs                                                                          Dmin                                                                         sGrs
  ----------------- -------- ---------------------------------------------------------------------------- ---------------------------------------------------------------------------- ----------------------------------------------------------------------------
  Control Group     Before   4.63±1.28                                                                    2.83±0.48                                                                    0.06±0.03
  (n=42)            After    3.27±0.82[\*](#t4f1){ref-type="table-fn"}                                    6.84±1.18[\*](#t4f1){ref-type="table-fn"}                                    0.08±0.04[\*](#t4f1){ref-type="table-fn"}
  Treatment Group   Before   4.60±1.37                                                                    2.97±0.56                                                                    0.04±0.02
  (n=42)            After    3.00±0.79[\*](#t4f1){ref-type="table-fn"}^[Δ](#t4f2){ref-type="table-fn"}^   8.52±1.27[\*](#t4f1){ref-type="table-fn"}^[Δ](#t4f2){ref-type="table-fn"}^   0.08±0.05[\*](#t4f1){ref-type="table-fn"}^[Δ](#t4f2){ref-type="table-fn"}^

Note:comparisons between groups

P\<0.05 compared with control group

p\<0.05.

4). Comparisons in Peripheral Blood IFN-γ {#sec2-7}
-----------------------------------------

The level of IL-4 decreased and the level of IFN-γincreased in two groups significantly (*P*\<0.05), but more significantly in treatment group. See [Table 5](#T5){ref-type="table"}.

###### 

Comparisons in Peripheral Blood IFN-γ (*x̄*±*s*)

  Group             Cases   Time     IL-4(ng/ml)                                                                     IFN\^(pg/ml)
  ----------------- ------- -------- ------------------------------------------------------------------------------- ----------------------------------------------------------------------------------
                            Before   1.643±0.652                                                                     150.369±34.146
  Control Group     42      After    1.336±0.433[\*](#t5f1){ref-type="table-fn"}                                     164.736±33.088[\*](#t5f1){ref-type="table-fn"}
                            Before   1.634±0.853                                                                     142.651±42.292
  Treatment Group   42      After    1.072±0.555[\*](#t5f1){ref-type="table-fn"} ^[Δ](#t5f2){ref-type="table-fn"}^   181.977±41.937[\*](#t5f1){ref-type="table-fn"} ^[Δ](#t5f2){ref-type="table-fn"}^

**Note:**comparisons between groups,

P\<0.05, compared with control group,

Ρ\<0.05.

Discussions {#sec1-4}
===========

Bronchial Hyper Responsiveness (BHR) cough is a common respiratory disease in clinic. According to modern medicine, bronchial inflammation is one of the important mechanisms to cause Bronchial Hyper Responsiveness. When airway stimulated by allergens or other substances, the level of Bronchial Responsiveness is increased by participation of various inflammatory cells, inflammatory mediator, cytokines and damage of bronchial epithelium and superior nerves (Zhu, 2003; Ricarda, 2004). Until now there is no effective treatment for Bronchial Hyper Responsiveness. It's reported that leukotriene receptor antagonists can alleviate inflammation of airways and relieve Bronchial Hyper Responsiveness. (Minoguchi et al, 2002).

In Chinese Traditional Medicine, the cough is caused by disorder of dispersive and descending function of lung and reverse flow of gas from lung. There was an appropriate metaphor in Medicine Thoughts to describe the cause of cough: "the lung is like a bell needs to be knocked. Wind, coldness, hotness, humidity, dryness knock it from outside; tiredness, bad mood and disordered diet knock it from inside". Diseased lung is the basic cause of cough. From many years' clinic experience, the writer sums up that the reason of Bronchial Hyper Responsiveness cough attacks frequently, lasts long and difficult to cure is Yin deficiency. Yin deficiency, disorder of throat and dispersive and descending cause cough; deficiency of Qi and Yin caused by pathogenic Qi, which leads to disfunction of zang-fu organs. Ziyinqingre treatment is significantly effective to Bronchial Hyper Responsiveness cough. The research proves that Ziyinqingre treatment can not only improve symptoms of cough, difficult expectoration and throat itching, but also increase Dmin and decrease sGrs, thus decrease bronchial responsiveness.

It has been widely accepted that ratio imbalance between Th1 and Th2 is the cause of bronchial inflammation. IFN-γ, which represent functions of Th1 and Th2, is a couple of antagonism cytokines. As Th2 size cytokines' representative, IL-4 is an indicator to reflect bronchial inflammation. Through promoting expression of IgE's low affinity receptors, IL-4 further promotes the synthesis and release of IgE. Besides, it plays an important role in collecting, chemotax and infiltration of eosinophiles. As Th1 size cytokines' representative, IFN\^can inhabit the generating of Th2 size cytokines IL-4 and block the synthesis of IgE, which inhabits allergenic-induced bronchial chronic inflammation and Bronchial Hyper Responsiveness in an effective way (Schmidt et al, 2012; Ito et al, 2012; Mao et al, 2003). In this research, Ziyinqingre treatment decrease the level of patients' IL-4 in peripheral blood, increase the level of IFN-γ, remains the balance of Th1/Th2 cells, as a result, it decreased the synthesis of IgE, alleviated bronchial inflammation, reduced bronchial responsiveness and therefore alleviate cough.
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